Order intake and sales declined slightly, mainly due to weakness in the agricultural sector, while other divisions showed resilience. Profitability was impacted by lower capacity utilization and restructuring costs, but the financial position remains strong with high cash and equity ratios. Guidanc…
Revenue and profit rose sharply in H1 2026, led by strong tobacco and processed food performance. Upward revisions to full-year guidance reflect robust pricing, FX gains, and RRP growth, with dividend guidance also increased.Based on Japan Tobacco Inc. [2914] Q2 2026 Audio Transcript — Jul. 30 2026…
Q2 revenue rose 20% year-over-year to $82 million, with record rental and service revenues and strong product sales. Adjusted EBITDA grew 37% to $26 million, and full-year guidance was raised. The business remains focused on fleet expansion, manufacturing growth, and geographic diversification.Base…
Second quarter net revenues rose 21% year-over-year to $491 million, with record results in advisory, municipal financing, and equity brokerage. Operating margin improved to 21.8%, and $215 million was returned to shareholders in H1. Outlook calls for stable Q3 revenues and continued disciplined ca…
Q2 sales rose 4% sequentially but fell 20% year-over-year due to New York Medicaid changes, prompting a successful pivot to the commercial segment, which saw 27% prescription growth in H1. EBIT profitability was achieved, and global expansion continues with launches in China and Korea expected in 2…
Record production and margin improvements drove a 57% year-over-year increase in adjusted EBITDAX for 2Q 2026. Strategic acquisitions and cost reductions supported higher guidance, while robust hedging and capital returns enhanced financial flexibility.Original document: Antero Resources Corporatio…
Q2 2026 saw double-digit revenue and profit growth, driven by strong performance in affordable medicines, specialty, and biosimilars. The pending Kashiv acquisition will create a fully integrated biosimilar platform, while guidance for 2026 was raised across all key metrics.Based on Amneal Pharmace…
Second quarter revenue exceeded expectations, driven by TS&S growth and strong new business signings, despite a 2% year-over-year decline due to ClearPath renewal timing. Gross margin expanded in TS&S, and the company reaffirmed full-year guidance, anticipating a strong Q4.Based on Unisys Corporati…
H1 2026 saw robust growth and profitability, led by Build and Design segments, with recurring revenues at 95% and SaaS at 80%. The HCSS acquisition expands market reach and will temporarily dilute margins, but strong cash flow and strategic investments in AI and SaaS support a positive outlook.Base…
Record Q2 results with 6% revenue and 7% Adjusted EBITDA growth, driven by strong infrastructure demand, disciplined execution, and acquisitions. 2026 guidance reaffirmed, with major Arcosa acquisition set to reinforce U.S. leadership and deliver significant synergies.Based on CRH PLC [CRH] Q2 2026…
RNS Number : 6239O Saba Capital Management L.P 30 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSO…
Explore more price target data and ratings for Transportadora de Gas del Sur SA TGS on the Forecasts tab, and track all previous and future analyst recommendations for Transportadora de Gas del Sur SA TGS in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet…
Explore more price target data and ratings for Takeda Pharmaceutical Company Limited on the Forecasts tab, and track all previous and future analyst recommendations for Takeda Pharmaceutical Company Limited in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactS…
Explore more price target data and ratings for Pampa Energia S.A. on the Forecasts tab, and track all previous and future analyst recommendations for Pampa Energia S.A. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This informat…
Explore more price target data and ratings for Koninklijke Philips N.V. NY Registry Shares on the Forecasts tab, and track all previous and future analyst recommendations for Koninklijke Philips N.V. NY Registry Shares in the dedicated News Flow.Select reference data provided by FactSet. Copyright…
Explore more price target data and ratings for The Magnum Ice Cream Company N.V. on the Forecasts tab, and track all previous and future analyst recommendations for The Magnum Ice Cream Company N.V. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Resea…
Explore more price target data and ratings for Herc Holdings Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Herc Holdings Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This informat…
Explore more price target data and ratings for Evercore Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Evercore Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not…
Explore more price target data and ratings for General Dynamics Corporation on the Forecasts tab, and track all previous and future analyst recommendations for General Dynamics Corporation in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research System…
Explore more price target data and ratings for Sprouts Farmers Market, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Sprouts Farmers Market, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research System…
